We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Multiomic Sequencing Solutions To Revolutionize Human Disease Research

Nanopore Sequence Still
Credit: Oxford Nanopore

Understanding the mechanisms of human disease requires a multiomic approach; however, legacy multiomic methods require multiple platforms and complex processes with lengthy turnaround times and considerable costs.

Nanopore sequencing achieves a multiomic approach – spanning genomics, epigenomics, single-cell transcriptomics and epitranscriptomics – on a single platform, maximizing the data generated from valuable tissue samples.

This whitepaper explores the capabilities of nanopore sequencing for immunology, neurology, cardiovascular disease and cancer research. 

Download this whitepaper to explore:

  • Direct analysis of native DNA and RNA without PCR bias
  • Unrestricted read lengths to reveal biology hidden by short reads
  • Case studies showcasing the benefits of nanopore sequencing across human disease research
Brought to you by
Download Your Whitepaper for FREE Below
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.